First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 3.2 USD -2.14% Market Closed
Updated: May 15, 2024

Aquestive Therapeutics Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aquestive Therapeutics Inc
Pre-Tax Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Pre-Tax Income
-$28.5m
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Pre-Tax Income
$20.1B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Pre-Tax Income
-$5.8B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Pre-Tax Income
-$1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Pre-Tax Income
$3.9B
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Pre-Tax Income
$7.6B
CAGR 3-Years
2%
CAGR 5-Years
20%
CAGR 10-Years
5%

See Also

What is Aquestive Therapeutics Inc's Pre-Tax Income?
Pre-Tax Income
-28.5m USD

Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Pre-Tax Income amounts to -28.5m USD.

What is Aquestive Therapeutics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
19%

Over the last year, the Pre-Tax Income growth was 14%. The average annual Pre-Tax Income growth rates for Aquestive Therapeutics Inc have been 19% over the past three years , 19% over the past five years .